註冊並分享邀請連結,可獲得影片播放與邀請獎勵。

IPO Newsroom
@IPONewsroom_
Your IPO newsroom. S-1 filings, pricing updates, debut coverage, and post-IPO performance.
加入 November 2024
109 正在關注    31.9K 粉絲
NOVO HOLDINGS-BACKED REZERA FILES FOR A NASDAQ IPO The clinical-stage company, which is developing oral NLRP3 inhibitors for cardiovascular and neurologic disease, plans to list under RZRA with Jefferies, TD Cowen and Cantor as joint bookrunners. Novo Holdings owned 24.42% and Blue Owl affiliates 24.03% before the IPO, per its SEC filing
顯示更多